Holen Sie sich die Stockscreener-App
1.08
0.92%
-0.01
Handel nachbörslich:
1.07
-0.01
-0.93%
Schlusskurs vom Vortag:
$1.09
Offen:
$1.11
24-Stunden-Volumen:
87,149
Relative Volume:
0.32
Marktkapitalisierung:
$13.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.70%
1M Leistung:
+49.25%
6M Leistung:
+32.03%
1J Leistung:
-92.11%
1-Tages-Spanne:
$1.04
$1.11
1-Wochen-Bereich:
$1.02
$1.25
52-Wochen-Spanne:
$0.375
$16.06
AEON Biopharma Inc. Stock (AEON) Company Profile
Firmenname
AEON Biopharma Inc.
Sektor
Branche
Telefon
(949) 354-6499
Adresse
5 Park Plaza, Suite 1750, Irvine
Vergleichen Sie AEON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
1.08 | 13.20M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-18 | Eingeleitet | H.C. Wainwright | Buy |
AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten
AEON Biopharma (NASDAQ:AEON) & Synaptogenix (NASDAQ:TAOX) Head to Head Analysis - Defense World
Why AEON Biopharma Inc. Class stock stays on buy listsJuly 2025 Trends & Low Drawdown Investment Ideas - ulpravda.ru
Will AEON Biopharma Inc. Class stock outperform foreign stocksWeekly Stock Report & Low Drawdown Trading Strategies - ulpravda.ru
What technical signals suggest for AEON Biopharma Inc. stockGDP Growth & Momentum Based Trading Ideas - ulpravda.ru
Midday Stock Roundup: Lantronix Stock up 4.8% Today - Orange County Business Journal
What dividend safety rating applies to AEON Biopharma Inc. Class stockWeekly Earnings Recap & Low Risk Entry Point Guides - ulpravda.ru
AEON Biopharma, Inc. Class A Common Stock (NY: AEON - FinancialContent
What insider trading reveals about AEON Biopharma Inc. stockHigh Yield Income Stocks & Ride the Wave of Market-Beating Growth - ulpravda.ru
2026 world cup star players explained: How AEON Biopharma Inc. Class stock compares with tech leaders2026 world cup usa national team third place match key players pressing system expert forecast preview - ulpravda.ru
2026 world cup match report guide: How AEON Biopharma Inc. stock benefits from global expansion2026 world cup usa national team semifinals defensive leaders pressing system winner prediction preview - ulpravda.ru
Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter2026 world cup usa national team qualification playmakers high defensive line odds analysis preview - ulpravda.ru
Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal
AEON Biopharma, Inc. (AEON) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
AEON Biopharma (NASDAQ:AEON) Trading Up 5.9% – Time to Buy? - Defense World
AEON Biopharma (AEON) seeks shareholder approval for PIPE, note exchange and equity plan - Stock Titan
Will AEON Biopharma Inc. stock split attract more investorsMomentum Trading Signals & Grow Generational Wealth With Ease - bollywoodhelpline.com
Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
Aug EndMonth: How AEON Biopharma Inc stock benefits from global expansionWeekly Profit Recap & Risk Managed Investment Strategies - moha.gov.vn
Insider Buy: Can AEON Biopharma Inc Class stock stage a strong rebound this quarterJuly 2025 Rallies & Low Drawdown Trading Techniques - moha.gov.vn
Is AEON Biopharma Inc. Class stock bottoming after sell offBond Market & Community Verified Trade Signals - Улправда
Investor Mood: Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter - Улправда
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
How AEON Biopharma Inc. stock benefits from global expansionEarnings Recap Summary & Weekly High Potential Stock Alerts - Улправда
AEONAeon Biopharma Latest Stock News & Market Updates - Stock Titan
Will AEON Biopharma Inc. Class stock benefit from infrastructure billWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
Biopharmaceutical company offers new hires stock units over four years - Stock Titan
[PRE 14A] AEON Biopharma, Inc. Preliminary Proxy Statement - Stock Titan
Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal
Is AEON Biopharma Inc. Class stock undervalued historicallyEarnings Overview Summary & Pattern Based Trade Signal System - DonanımHaber
Will AEON Biopharma Inc. Class stock sustain dividend payoutsJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - DonanımHaber
Will AEON Biopharma Inc. stock recover faster than marketMarket Sentiment Review & Smart Allocation Stock Reports - DonanımHaber
AEON Biopharma Earnings Notes - Trefis
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong - The Manila Times
AEON Biopharma IncExchange to Eliminate Ov - 富途牛牛
AEON Biopharma announces execution of exchange agreement with Daewoong Pharmaceutical - MSN
Aeon Biopharma announces execution of exchange agreement with Daewoong - marketscreener.com
AEON Biopharma Announces Exchange Agreement with Daewoong - TipRanks
AEON Biopharma announces exchange agreement with Daewoong - MSN
AEON Biopharma signs Daewoong note exchange with equity and warrants | AEON SEC FilingForm 8-K - Stock Titan
AEON Biopharma (NYSE: AEON) agrees Daewoong swap cutting over 90% of debt - Stock Titan
AEON and Daewoong finalize $15 million debt-to-equity exchange deal - Investing.com
Aeon Biopharma Continues Push to Commercialization - Orange County Business Journal
AEON Biopharma (AEON) Price Target Decreased by 15.28% to 6.22 - Nasdaq
AEON Biopharma Releases New Corporate Presentation - The Globe and Mail
How AEON Biopharma Inc. Class stock performs in volatility spikesQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Can AEON Biopharma Inc. Class stock retain market dominanceJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
Finanzdaten der AEON Biopharma Inc.-Aktie (AEON)
Es liegen keine Finanzdaten für AEON Biopharma Inc. (AEON) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
Kapitalisierung:
|
Volumen (24h):